Trademark Index the Trademarked Terms on This List Appear in VWR Publications and on This Web Site
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
View/Download
Solutions for Affordable Rental Housing in the Delaware Valley r-- - 0 0 0 DDD DDD /-""" D D •• DELAWARE VALLEY' REGIONAL PLANNING COMMISSION va August 1994 The preparation of this report was funded through federal grants from the U. S. Department of Transportation's Federal Highway Administration (FHW A) and Federal Transit Administration (FTA), the Pennsylvania and New Jersey Departments of Transportation as well as by DVRPC's state and local member governments. The authors, however, are solely responsible for its [mdings and conclusions, which may not represent the official views or policies of the funding agencies. Created in 1965, the Delaware Valley Regional Planning Commission (DVRPC) is an interstate, intercounty and intercity agency which provides continuing, comprehensive and coordinated planning for the orderly growth and development of the Delaware Valley region. The region includes Bucks, Chester, Delaware, and Montgomery counties as well as the City of Philadelphia in Pennsylvania and Burlington, Camden, Gloucester, and Mercer counties in New Jersey. The Commission is an advisory agency which divides its planning and service functions between the Office of the Executive Director, the Office of Public Affairs, and three line Divisions: Transportation Planning, Regional Planning, and Administration. DVRPC's mission for the 1990s is to emphasize technical assistance and services and to conduct high priority studies for member state and local governments, while determining and meeting the needs of the private sector. The DVRPC logo is adapted from the official seal of the Commission and is designed as a stylized image of the Delaware Valley. The outer ring symbolizes the region as a whole while the diagonal bar signifies the Delaware River flowing through it. -
Offizielle Mitteilung Der Schweizer Boerse
Bekanntmachung auf KeyInvest Änderung der Valorennummer und ISIN der Unilever N.V. Change of the Valor number and ISIN of Unilever N.V. Im Zusammenhang mit der Änderung der Valorennummer und ISIN der Unilever N.V. (Bloomberg Code: UNA NA) wurden die Bedingungen der unten genannten Produkte der UBS AG, per 1. Juli 2019 angepasst. Die detaillierten Informationen befinden sich in der entsprechenden Produktedokumentation (Termsheets). With regard to the change of the Valor number and ISIN of Unilever N.V. (Bloomberg Code: UNA NA) UBS AG will adjust the terms of the following products as of 1st July 2019. Detailed information can be found in the respective product documentation (Termsheets). ISIN Name CH0391674139 6.25% p.a. EUR Kick-In GOAL linked to worst of Henkel / Unilever / Beiersdorf / BASF CH0400505621 6.50% p.a. CHF Kick-In GOAL linked to worst of Unilever / Nestlé / Anheuser-Busch / Danone CH0420778752 5.00% p.a. EUR Kick-In GOAL linked to worst of Carrefour / Danone / Nestlé / Unilever CH0410512831 5.50% p.a. EUR Kick-In GOAL linked to worst of Nestlé / Unilever / Danone / Kellogg CH0426877814 5.50% p.a. CHF Kick-In GOAL linked to worst of Barry Callebaut / Mondelez / Danone / Unilever CH0434742570 5.50% p.a. EUR Kick-In GOAL linked to worst of Beiersdorf / Henkel / LOréal / Unilever CH0456067161 8.00% p.a. EUR Callable Kick-In GOAL linked to worst of adidas / LOréal / Unilever / Carrefour CH0468335655 6.00% p.a. EUR Callable Kick-In GOAL linked to worst of Mondelez / Danone / Unilever CH0472609830 8.00% p.a. EUR Kick-In GOAL linked to worst of Carrefour / Danone / Unilever CH0477599200 8.50% p.a. -
South Dakota Board of Pharmacy Wholesale Distributors; Active, in Good Standing As of October 5, 2018 This Document May Be Used As a Primary Source Verification
South Dakota Board of Pharmacy Wholesale Distributors; Active, in good standing as of October 5, 2018 This document may be used as a Primary Source Verification Full License Firm Name DBA Address 1 Address 2 City State ZIP Code Expiration Issued 600-2353 3M COMPANY dba 3M ESPE DENTAL PRODUCTS 2111 MCGAW AVE IRVINE CA 92614 12/31/2018 11/10/2014 3M COMPANY-CRITICAL & CHRONIC 600-1277 CARE SOLUTIONS DIVISION dba 3M 601 22ND AVE S BROOKINGS SD 57006 12/31/2018 03/19/2007 600-0107 A & B WELDING SUPPLY CO INC 914 E CHICAGO ST RAPID CITY SD 57701 12/31/2018 01/28/1992 600-1251 A.F. HAUSER INC 4401 E US HWY 30 VALPARAISO IN 46383 12/31/2018 01/03/2007 600-2272 A.P.I. SOLUTIONS INC 25309 FRIENDSHIP RD DAPHNE AL 36526 12/31/2018 03/06/2014 ABBVIE PATIENT ASSISTANCE 600-1372 FOUNDATION 1 N WAUKEGAN RD D-ZZ22, BLDG AP34 NORTH CHICAGO IL 60064 12/31/2018 11/20/2007 600-2058 ABBVIE US LLC 1 N WAUKEGAN RD D-GS02 BLDG AP5 NORTH CHICAGO IL 60064 12/31/2018 07/19/2012 600-2299 ABRAXIS BIOSCIENCE LLC 86 MORRIS AVE SUMMIT NJ 07901 12/31/2018 05/22/2014 600-2952 ACACIA PHARMA INC 440 STEVENS AVE, SUITE 200 SOLANA BEACH CA 92075 12/31/2019 09/27/2018 600-2358 ACADIA PHARMACEUTICALS INC 3611 VALLEY CENTRE DR STE 300 SAN DIEGO CA 92130 12/31/2018 11/19/2014 600-2409 ACARIAHEALTH SOLUTIONS INC 6610 W SAM HOUSTON PKWY N#330 HOUSTON TX 77041 12/31/2018 04/06/2015 600-1552 ACCERA INC 3005 CENTER GREEN DR #205 BOULDER CO 80301 12/31/2018 01/08/2009 600-2657 ACCORD BIOPHARMA INC 1009 SLATER RD STE 210-B DURHAM NC 27703 12/31/2018 11/07/2016 600-1472 ACCORD HEALTHCARE -
AAFES Million-Dollar Vendors
AAFES Fiscal 2010 AAFES Million-Dollar Vendors he following list, based on information furnished by the Army & Air that there has been no change in the way beverages are purchased by the Force Exchange Service (AAFES), identifies 755 AAFES suppliers do- exchange service. ing more than $1 million in business with the exchange service in fiscal T The number of million-dollar companies is exactly the same as it was on 2010. According to the exchange service, the fiscal 2010 list is based on sales versus finance and accounting payments. This list does not include the fiscal 2010 list, and the club continues to be an exclusive one. Its mem- government agencies, foreign vendors paid in foreign currencies or any bership list is an honor roll testifying to quality merchandise and sustained payments made manually. performance. Additionally, in several cases, sales that have on previous lists been In some cases in which each of two or more divisions of a single com- credited to brewers, distillers or beverage manufacturers show up on the pany did more than $1 million in business with AAFES, sales from divisions/ current list credited to distributors or bottlers. AAFES attributes the dif- subsidiaries have been combined into a single total. In others, the divisions ferences to consolidation and brand shifts within the industry and confirms are listed separately and are marked with an asterisk (*). FY10 FY09 VENDOR NAME FY10 SALES FY10 FY09 VENDOR NAME FY10 SALES FY10 FY09 VENDOR NAME FY10 SALES 1 22 Truman Arnold Co. $294,992,677 40 30 Whirlpool Corp.* $23,018,202 78 77 Sheralven Enterprises Ltd. -
Danaher Corp /De
DANAHER CORP /DE/ FORM 10-K (Annual Report) Filed 3/15/2006 For Period Ending 12/31/2005 Address 2099 PENNSYLVANIA AVE N.W., 12TH FLOOR WASHINGTON, District of Columbia 20006 Telephone 202-828-0850 CIK 0000313616 Industry Scientific & Technical Instr. Sector Technology Fiscal Year 12/31 Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2005 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-8089 DANAHER CORPORATION (Exact name of registrant as specified in its charter) Delaware 59 -1995548 (State of incorporation) (I.R.S.Employer Identification number) 2099 Pennsylvania Ave. N.W., 12 th Floor Washington, D.C. 20006-1813 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: 202-828-0850 Securities Registered Pursuant to Section 12(b) of the Act: Title of each class Name of Exchanges on which registered Common Stock $.01 par value New York Stock Exchange Pacific Exchange Securities registered pursuant to Section 12(g) of the Act: NONE (Title of Class) Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. -
Notice of the Annual Stockholders' Meeting
OF THE OF on April 27, 2012 NOTICE MEETING OF BAYER AG MEETING OF BAYER ANNUAL STOCKHOLDERS’ STOCKHOLDERS’ ANNUAL Please fill out in block letters Please Surname affix stamp First Name Street and house number Postal code Bayer AG c /o Finger Marketing Services Country Postfach 100538 41405 Neuss E-mail Germany Phone 2 CONTENTS NOTICE OF THE ANNUAL STOCKHOLDERS’ MEETING 2012 NOTICE OF THE ANNUAL STOCKHOLDERS’ MEETING 2012 KEY DATA 23 Contents Key data 2010 2011 Change AGENDA € million € million % Sales 35,088 36,528 + 4.1 1. Presentation of the adopted annual fi nancial 3 EBIT 1 2,730 4,149 + 52.0 statements and the approved consolidated fi nancial EBIT before special items 2 4,452 5,025 + 12.9 statements, the combined management report, the re- EBITDA 3 6,286 6,918 + 10.1 port of the Supervisory Board, the explanatory report by EBITDA before special items 2 7,101 7,613 + 7.2 the Board of Management on takeover-related disclosu- EBITDA margin before special items 4 20.2% 20.8% res, and the proposal by the Board of Management on the Income before income taxes 1,721 3,363 + 95.4 one-time delivery delivery regular one-time delivery delivery regular appropriation of distributable profi t for the fi scal year as an app and on the internet Net income 1,301 2,470 + 89.9 2011, as well as the resolution on the appropriation of Earnings per share (€) 5 1.57 2.99 + 90.4 distributable profi t. Core earnings per share (€) 6 4.19 4.83 + 15.3 2. -
The Korn/Ferry Market Cap 100 Board Leadership at America’S Most Valuable Public Companies About the 2010 Korn/Ferry Market Cap 100
The Korn/Ferry Market Cap 100 Board leadership at America’s most valuable public companies About the 2010 Korn/Ferry Market Cap 100 The Korn/Ferry Market Cap 100 (KFMC100) comprises the U.S. companies traded on the NYSE or NASDAQ , excluding public investment firms, with the largest market capitalization as of the close of market on May 3, 2010, after reporting for the 2009 fiscal year. Data about the companies’ boards, compiled from proxies related to fiscal year 2009, provide the baseline for this report. B Contents Introduction . 2 Board leadership in an era of change . 4 What’s in a name? . 4 Portrait of a lead director . 6 Interview with Mark Ketchum . 8 Lead director, Kraft Foods Adding value to the board . 12 Interview with Irv Hockaday . 14 Presiding director, Ford Motor Co. and Estée Lauder Companies Inc. Committee membership and leadership . 16 Leadership succession on the board . 18 Assessing the need for terms . 19 Interview with Bonnie G. Hill . 20 Lead director, The Home Depot, Inc. Compensating for time and value . 22 Final thoughts and best practices . 24 Appendix A . 25 Board data Appendix B . 32 List of the KFMC100 companies Appendix C . 35 List of the KFMC100 non-executive board leaders Introducing the Korn/Ferry Market Cap 100 The Korn/Ferry Market Cap 100 (KFMC100) marks a new approach to the governance research our firm has undertaken for thirty-five years. We’ve chosen to examine the United States’ one hundred most valuable compa- nies, working from the assumption that leadership models represented on these boards are worth observing and emulating. -
DANAHER CORPORATION (Exact Name of Registrant As Specified in Its Charter)
DANAHER CORP /DE/ FORM 10-K (Annual Report) Filed 3/10/2004 For Period Ending 12/31/2003 Address 2099 PENNSYLVANIA AVE N.W., 12TH FLOOR WASHINGTON, District of Columbia 20006 Telephone 202-828-0850 CIK 0000313616 Industry Scientific & Technical Instr. Sector Technology Fiscal Year 12/31 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-8089 DANAHER CORPORATION (Exact name of registrant as specified in its charter) Delaware 59-1995548 (State of incorporation) (I.R.S.Employer Identification number) 2099 Pennsylvania Ave. N.W., 12 th Floor Washington, D.C. 20006 -1813 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: 202-828-0850 Securities Registered Pursuant to Section 12(b) of the Act: Title of each class Name of Exchanges on which registered Common Stock $.01 par Value New York Stock Exchange, Inc. Pacific Stock Exchange, Inc. Securities registered pursuant to Section 12(g) of the Act: NONE (Title of Class) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. -
QUAKER CHEMICAL CORPORATION (Exact Name of Registrant As Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 January 30, 2013 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of Registrant as specified in its charter) Commission File Number 001-12019 PENNSYLVANIA No. 23-0993790 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) One Quaker Park 901 E. Hector Street Conshohocken, Pennsylvania 19428 (Address of principal executive offices) (Zip Code) (610) 832-4000 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) INFORMATION TO BE INCLUDED IN THE REPORT Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 30, 2013, the Board of Directors (the "Board") of Quaker Chemical Corporation (the "Company") decided to temporarily increase the size of the Board from nine to ten and appointed Mark A. -
Download New Glass Review 15
eview 15 The Corning Museum of Glass NewGlass Review 15 The Corning Museum of Glass Corning, New York 1994 Objects reproduced in this annual review Objekte, die in dieser jahrlich erscheinenden were chosen with the understanding Zeitschrift veroffentlicht werden, wurden unter that they were designed and made within der Voraussetzung ausgewahlt, daB sie inner- the 1993 calendar year. halb des Kalenderjahres 1993 entworfen und gefertigt wurden. For additional copies of New Glass Review, Zusatzliche Exemplare der New Glass Review please contact: konnen angefordert werden bei: The Corning Museum of Glass Sales Department One Museum Way Corning, New York 14830-2253 Telephone: (607) 937-5371 Fax: (607) 937-3352 All rights reserved, 1994 Alle Rechte vorbehalten, 1994 The Corning Museum of Glass The Corning Museum of Glass Corning, New York 14830-2253 Corning, New York 14830-2253 Printed in Frechen, Germany Gedruckt in Frechen, Bundesrepublik Deutschland Standard Book Number 0-87290-133-5 ISSN: 0275-469X Library of Congress Catalog Card Number Aufgefuhrt im Katalog der Library of Congress 81-641214 unter der Nummer 81 -641214 Table of Contents/lnhalt Page/Seite Jury Statements/Statements der Jury 4 Artists and Objects/Kunstlerlnnen und Objekte 10 Bibliography/Bibliographie 30 A Selective Index of Proper Names and Places/ Ausgewahltes Register von Eigennamen und Orten 58 etztes Jahr an dieser Stelle beklagte ich, daB sehr viele Glaskunst- Jury Statements Ller aufgehort haben, uns Dias zu schicken - odervon vorneherein nie Zeit gefunden haben, welche zu schicken. Ich erklarte, daB auch wenn die Juroren ein bestimmtes Dia nicht fur die Veroffentlichung auswahlen, alle Dias sorgfaltig katalogisiert werden und ihnen ein fester Platz in der Forschungsbibliothek des Museums zugewiesen ast year in this space, I complained that a large number of glass wird. -
Discovering and Developing Innovative New Medicines Designed to Extend and Enhance the Quality of Human Life
® Discovering and developing innovative new medicines designed to extend and enhance the quality of human life. 2011 Annual Report Company Profile Athersys is an international, clinical-stage biotechnology company that is focused on developing novel and proprietary best-in-class therapies designed to treat significant unmet medical needs that extend and enhance the quality of human life. The Company is developing MultiStem®, a patented, adult-derived “off-the- shelf” stem cell product platform for multiple disease indications in the inflammatory & immune, neurological and cardiovascular disease areas. Current clinical-stage programs include: an ongoing Phase II trial to treat inflammatory bowel disease (partnered with Pfizer); an ongoing Phase II trial to treat damage from ischemic stroke; a recently completed Phase I trial to treat damage from acute myocardial infarction (heart attack); and a recently completed Phase I trial to prevent or reduce GvHD. MultiStem® Production Process Athersys has forged a network of strategic Scalable & Consistent alliances and collaborations with leading pharmaceutical and biotechnology Isolate Material “Off-the-shelf” Product with from Qualified Commercial Scalability Thaw & Administer companies, as well as world- Adult Donor (No tissue matching– renowned research and clinical Lot Release & Product allogeneic product) Characterization Testing Hundreds of thousands institutions in the United to millions of doses States and Europe to PRODUCT STERILITY obtained per donor further develop its Cell Isolation -
Henkel AG & Co. Kgaa
Second Supplement dated 14 January 2020 to the Prospectus dated 4 July 2019 as supplemented by the First Supplement dated 18 September 2019 This document constitutes a supplement (the "Second Supplement") within the meaning of Article 46(3) of Regulation (EU) 2017/1129 of the European Parliament and the Council of 14 June 2017 (the "Prospectus Regulation") in connection with Article 13 Luxembourg law relating to prospectuses for securities dated 10 July 2005, as amended, (Loi relative aux prospectus pour valeurs mobilières, the "Luxembourg Law 2005"), which implemented Directive 2003/71/EC of the European Parliament and the Council of 4 November 2003, as amended (the "Prospectus Directive") to the base prospectus of Henkel AG & Co. KGaA in respect of non- equity securities within the meaning of Art. 22 No. 6(4) of the Commission Regulation (EC) No. 809/2004 of 29 April 2004, as amended, ("Non-Equity Securities") (the "Debt Issuance Programme Prospectus" or the "Prospectus"). This Second Supplement is supplemental to, and must be read in conjunction with the Debt Issuance Programme Prospectus dated 4 July 2019 as supplemented by the first supplement dated 18 September 2019 (the "First Supplement") (the Prospectus together with the First Supplement, the "Supplemented Prospectus"). Henkel AG & Co. KGaA (Düsseldorf, Federal Republic of Germany) as Issuer EUR 6,000,000,000 Debt Issuance Programme (the "Programme") The Issuer has requested the Luxembourg Commission de Surveillance du Secteur Financier (the "Commission") in its capacity as competent